IBEX affiliate plans $1.0M Rule 144 stock sale

An affiliate of IBEX Ltd filed a Rule 144 notice for a planned sale of up to 25,000 common shares through an agent.

Available on EDGAR 09/15/2026 - 04:18 PM EDT Accepted by SEC EDGAR 09/15/2026 - 04:17 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

IBEX Ltd (IBEX) has a notice of proposed sale under Rule 144 for its common stock. The filing covers a potential sale of up to 25,000 shares of common stock for the account of affiliate Robert Dechant, with J.P. Morgan Securities LLC acting as agent. The shares relate to equity compensation awards, including performance share units that vested on July 1, 2025, October 2, 2025, and February 6, 2026. Shares of IBEX common stock are listed on NASDAQ.

Key Figures

Shares proposed for sale: 25,000 shares of common stock Approximate aggregate market value: $999,667.15 Shares outstanding: 13,389,116 shares +4 more

7 metrics

Shares proposed for sale 25,000 shares of common stock Maximum number of IBEX Ltd shares covered by the Rule 144 notice

Approximate aggregate market value $999,667.15 Market value associated with the 25,000 IBEX Ltd shares proposed for sale

Shares outstanding 13,389,116 shares IBEX Ltd common shares outstanding cited alongside the Rule 144 sale information

PSU Vest equity compensation (July 1, 2025) 3,812 shares Common shares from PSU vesting designated as Equity Compensation on July 1, 2025

PSU Vest equity compensation (February 6, 2026) 21,175 shares Common shares from PSU vesting designated as Equity Compensation on February 6, 2026

PSU Vest equity compensation (October 2, 2025) 13 shares Common shares from PSU vesting designated as Equity Compensation on October 2, 2025

Filing signature date September 15, 2026 Date associated with the remarks and signature for the Rule 144 notice

Key Terms

Rule 144, affiliate, Equity Compensation, PSU Vest

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

affiliate regulatory

"affiliate 144: Securities Information"

Equity Compensation financial

"3812 | 07/01/2025 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

PSU Vest financial

"Common | 07/01/2025 | PSU Vest | IBEX Ltd"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for IBEX (IBEX)?

It discloses a planned sale under Rule 144 of up to 25,000 shares of IBEX Ltd common stock for the account of affiliate Robert Dechant, with J.P. Morgan Securities LLC acting as agent.

How many IBEX (IBEX) shares are proposed to be sold and on what market?

The notice covers a potential sale of 25,000 shares of IBEX Ltd common stock, listed on NASDAQ. The filing associates this with an approximate market value of $999,667.15.

Who is the selling security holder in this IBEX (IBEX) Form 144?

The securities are to be sold for the account of Robert Dechant, identified as an affiliate, with J.P. Morgan Securities LLC, Workplace Solutions, acting as agent and attorney-in-fact.

What is the relationship between the IBEX (IBEX) shares and equity compensation?

The Form 144 describes the securities to be sold as Common shares arising from PSU Vest transactions designated as Equity Compensation on July 1, 2025, October 2, 2025, and February 6, 2026.

How many IBEX (IBEX) shares are outstanding according to the notice?

The filing lists approximately 13,389,116 shares of IBEX Ltd common stock outstanding in connection with the Rule 144 sale information.

What is the approximate market value of the IBEX (IBEX) shares covered by this Rule 144 notice?

The Rule 144 notice shows an approximate aggregate market value of $999,667.15 for the 25,000 IBEX Ltd common shares that are proposed to be sold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001298255
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IBEX LIMTED
SEC File Number	001-38442
Address of Issuer	1717 PENNSYLVANIA AVENUE NW SUITE 825 WASHINGTON DISTRICT OF COLUMBIA 20006
Phone	202-580-6200
Name of Person for Whose Account the Securities are To Be Sold	Robert Dechant
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 270 Park Ave 10th Floor New York NY 10017	25000	999667.15	13389116	09/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/01/2025	PSU Vest	IBEX Ltd (Issuer)			3812	07/01/2025	Equity Compensation
Common	02/06/2026	PSU Vest	IBEX Ltd (Issuer)			21175	02/06/2026	Equity Compensation
Common	10/02/2025	PSU Vest	IBEX Ltd (Issuer)			13	10/02/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	J.P. Morgan Securities LLC, Workplace Solutions, as Agent and Attorney in Fact for Robert Dechant, IBEX Limited
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)